Peter Sleight

Medicine · Health Sciences

104h-index73.9kcitations622works39.72yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Heart Rate Variability and Autonomic Control(180), Blood Pressure and Hypertension Studies(138), Cardiovascular and exercise physiology(65), Cardiovascular Syncope and Autonomic Disorders(51), Heart Failure Treatment and Management(50)

Publications617 total

Blood pressure lowering in isolated diastolic hypertension and cardiovascular risk: an individual patient data meta-analysis
European Heart Journal·2025· 2 citedOpen Access
ASCEND-Eye
Ophthalmology·2024· 6 citedOpen Access
ASCEND-Eye
Ophthalmology·2023· 13 citedOpen Access
Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials
The Lancet·2022· 222 citedOpen Access
Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis
The Lancet Diabetes & Endocrinology·2022· 95 citedOpen Access
Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis
The Lancet·2021· 300 citedOpen Access
Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis
The Lancet·2021· 925 citedOpen Access
Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis
The Lancet Oncology·2021· 101 citedOpen Access
Serious Adverse Effects of Extended-release Niacin/Laropiprant: Results From the Heart Protection Study 2–Treatment of HDL to Reduce the Incidence of Vascular Events (HPS2-THRIVE) Trial
Clinical Therapeutics·2019· 28 cited
Impact of <i>ADCY9</i> Genotype on Response to Anacetrapib
Circulation·2019· 34 citedOpen Access
Cost-effectiveness of lipid lowering with statins and ezetimibe in chronic kidney disease
Kidney International·2019· 19 citedOpen Access
Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials
The Lancet·2019· 763 citedOpen Access
Impact of CKD on Household Income
Kidney International Reports·2017· 38 citedOpen Access
Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation
Kidney International·2017· 39 citedOpen Access
Relative and Combined Prognostic Importance of On-Treatment Mean and Visit-to-Visit Blood Pressure Variability in ONTARGET and TRANSCEND Patients
Hypertension·2017· 37 cited
Peter Joseph Wilkinson Monks
BMJ·2017
Prognostic Impact of Diabetes and Prediabetes on Survival Outcomes in Patients With Chronic Heart Failure: A Post‐Hoc Analysis of the GISSI‐HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca‐Heart Failure) Trial
Journal of the American Heart Association·2017· 68 citedOpen Access
Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP)
American Journal of Kidney Diseases·2016· 81 citedOpen Access
Cost-effectiveness of Simvastatin plus Ezetimibe for Cardiovascular Prevention in CKD: Results of the Study of Heart and Renal Protection (SHARP)
American Journal of Kidney Diseases·2015· 27 citedOpen Access
Music and the heart.
PubMed·2015· 1 cited
page 1 of 31Next →

Frequent Co-authors

Salim Yusuf(15), Richard Peto(11), Rory Collins(11), Colin Baigent(11), Robert Fagard(8), Sarah Parish(8), Alberto Zanchetti(7), Sverre E. Kjeldsen(7), Giuseppe Mancia(7), Stephen MacMahon(7), Faı̈ez Zannad(6), Martin Landray(6), Aldo P. Maggioni(6), Krzysztof Narkiewicz(5), Josep Redón(5), Renata Cífková(5), Anna F. Dominiczak(5), Maurizio Galderisi(5), Diederick E. Grobbee(5), Tiny Jaarsma(5)